Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| The Zacks Analyst Blog Highlights: The Goldman Sachs Group, Lloyd's, Bank of ... - Zacks.com |
 |
 |
|
Zacks.com KAI-4169, the lead candidate at KAI Pharmaceuticals, is being evaluated for the treatment of secondary hyperparathyroidism (SHPT) in chronic kidney disease (CKD) patients on dialysis. SHPT is a common and serious complication for the above patient |
